PEMF Therapy
Pulsed electromagnetic field therapy to enhance cellular function, reduce inflammation, and support bone and tissue healing.
Evidence Summary
Pulsed electromagnetic field (PEMF) therapy applies low-frequency magnetic pulses that induce microcurrents in tissue. It is FDA-cleared to stimulate bone healing (including nonunions) and, as transcranial magnetic stimulation, for depression. A 2026 systematic review and meta-analysis of 9 randomized controlled trials (457 patients) in knee osteoarthritis found time- and parameter-dependent benefits: WOMAC pain improved significantly at 18-21 days (mean difference -1.63), while WOMAC stiffness (-1.11) and daily-activity function (-3.39) improved significantly at one month; VAS pain and total WOMAC did not reach significance, and overall risk of bias was high. For acute fracture healing the evidence is mixed - a 2024 systematic review update of 3 RCTs did not support PEMF for acute fractures - but a 2025 network meta-analysis of 39 fracture studies (2,379 patients) found physical-agent modalities collectively shortened time to union (-21.6 days) and raised complete-healing rates (RR 1.37), and a 2026 multicenter series reported 91% healing of fifth-metatarsal nonunions by 12 months. Benefits appear real but modest and highly dependent on device parameters, and protocols remain poorly standardized. Educational information, not medical advice.
Evidence Scale
Mechanism of Action
Pulsed magnetic fields induce low-level electrical currents in tissue that modulate ion channels (notably calcium signaling), cell-membrane potential and downstream pathways involved in osteoblast activity, chondrocyte function and inflammatory signaling. Proposed effects include enhanced ATP production, upregulated osteogenic and growth-factor signaling, and reduced pro-inflammatory cytokines, supporting bone and soft-tissue repair.
Who Is This For?
Pain reduction, bone healing, cellular optimization, recovery enhancement, sleep improvement.
Protocol & Dosing
Dose
Varies by condition and device. Typically 8-30 minute sessions.
Frequency
Daily to 3x/week
Duration
Ongoing or course-based
Protocol Summary
Mat, pad, or local applicator. Frequency and amplitude are selected by goal: low-frequency settings for relaxation and sleep, higher-energy protocols for bone and tissue healing. Sessions typically 8-30 minutes, daily to 3x/week, as a course or ongoing.
Latest Evidence
2024–2026: nuanced benefits in knee osteoarthritis, mixed signal for fractures
A 2026 systematic review and meta-analysis of 9 randomized controlled trials (457 patients) found PEMF's effect on knee osteoarthritis is real but time- and parameter-dependent. WOMAC pain improved significantly at 18–21 days (mean difference −1.63), while WOMAC stiffness (−1.11) and daily-activity function (−3.39) improved significantly at one month. VAS pain and total WOMAC did not reach significance, objective functional tests were unchanged, and the overall risk of bias across trials was high. The authors note high frequency tends to give faster pain relief while higher amplitude supports function.
For bone healing the picture is mixed. A 2024 systematic-review update of 3 RCTs did not support PEMF for acute fractures, but a 2025 network meta-analysis of 39 fracture studies (2,379 patients) found physical-agent modalities collectively shortened time to union by about 21.6 days and raised complete-healing rates (RR 1.37), and a 2026 multicenter series reported roughly 91% healing of fifth-metatarsal nonunions by 12 months. PEMF remains FDA-cleared for stimulating bone healing and, as transcranial magnetic stimulation, for depression.
Benefits are modest and depend heavily on device parameters, which remain poorly standardized; reported improvements may not always reach thresholds for clinical meaningfulness. PEMF is an adjunct, not a substitute for medical care, and is contraindicated with pacemakers or implanted electronics and in pregnancy. Educational information, not medical advice.
Systematic review & meta-analysis · 9 RCTs · 457 patients · 2026
PEMF vs control: symptom change in knee osteoarthritis
Mean difference vs control (negative = improvement) with 95% confidence-interval whiskers, pooled across 9 randomized controlled trials (457 patients) in knee osteoarthritis. The accent bars reached statistical significance; the grey bar (VAS pain) did not, and overall risk of bias was rated high. Source: Chang, Lin & Huang, Medicina (2026).
Related on Peak Human
Red Light Therapy
A companion energy-based recovery modality in the database.
Hyperbaric Oxygen (HBOT)
Another cellular-energy and recovery therapy offered at Peak Human.
Performance & Recovery
Where PEMF fits as a recovery and tissue-repair tool.
Sleep
Low-frequency PEMF settings are used for relaxation and sleep.
Diagnostic Testing
Track pain, function and recovery to guide use and dose.
Peak Human Shop
Practitioner-selected recovery tools and devices.
Key references: PEMF therapy in knee osteoarthritis: systematic review & meta-analysis — Medicina (2026) · Physical agent modalities in fractures: systematic review & network meta-analysis — Front. Med. (2025) · Effects of PEMF on bone fractures: systematic review update — Eur. J. Phys. Rehabil. Med. (2024) · PEMF for fifth-metatarsal fracture nonunion — Orthopedic Reviews (2026)
Interactions & Precautions
Contraindications
- Pacemakers/implanted electronics
- Pregnancy
- Epilepsy (for TMS)
Potential Risks
- •Device quality variation
- •Limited standardization
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Device parameters (frequency, amplitude, waveform, dose) drive results and are not interchangeable; low frequencies are used for relaxation and sleep, higher-energy protocols for bone and tissue healing. Evidence in knee osteoarthritis is timing- and parameter-dependent and clinically modest - set realistic expectations and track response. The strongest, FDA-cleared role is adjunctive bone-healing stimulation for delayed and nonunion fractures. Contraindicated with pacemakers or implanted electronics and in pregnancy. Device quality varies widely.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation